Results 51 to 60 of about 49,586 (211)

Prevalence of transthyretin cardiac amyloidosis in undifferentiated heart failure with preserved ejection fraction

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1176-1182, April 2025.
Abstract Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasinglyrecognized cause of heart failure with preserved ejection fraction (HFpEF), which may be diagnosed non‐invasively using 99mTc 3,3‐diphosphono‐1,2‐propanodicarboxylic acid (DPD) scintigraphy‐based diagnostic criteria.
L. Healy   +15 more
wiley   +1 more source

Observation and abstract behaviour in specification and implementation of state-based systems [PDF]

open access: yes, 2001
Classical algebraic specification is an accepted framework for specification. A criticism which applies is the fact that it is functional, not based on a notion of state as most software development and implementation languages are.
Pahl, Claus
core   +2 more sources

Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients

open access: yesBMC Cardiovascular Disorders, 2023
Background Transthyretin amyloidosis cardiomyopathy (ATTR-CM) patients are often older and may be at risk for obstructive epicardial coronary artery disease (oeCAD).
Rana Hassan   +4 more
doaj   +1 more source

Utility of Genetic Testing in Patients with Transthyretin Amyloid Cardiomyopathy: A Brief Review

open access: yesBiomedicines, 2023
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly diagnosed condition. Although wild-type transthyretin amyloidosis (ATTRwt) is the most common ATTR-CM, hereditary transthyretin amyloidosis (ATTRv) may also occur.
Ana-Maria Merino-Merino   +4 more
doaj   +1 more source

Reliability and validity of the Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire impact scales

open access: yesJournal of Patient-Reported Outcomes
Background The diversity of disease phenotypes associated with transthyretin (ATTR) amyloidosis poses challenges for measurement of health outcomes. The Transthyretin Amyloidosis – Quality of Life (ATTR-QOL) Questionnaire is a disease-specific patient ...
Andrew Lovley   +7 more
doaj   +1 more source

Extending Globus to support Multicast Transmission [PDF]

open access: yes, 2008
Proceedings of the 2004 UK e-Science All hands Meeting, 31st August - 3rd September, Nottingham UKThe Globus Toolkit is an open source software toolkit that has become the de-facto standard for middleware used to build Grid services.
Crowcroft, Jon, Jeacle, Karl
core  

An automated ETL for online datasets [PDF]

open access: yes, 2019
While using online datasets for machine learning is commonplace today, the quality of these datasets impacts on the performance of prediction algorithms.
McCarren, Andrew   +2 more
core   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer   +25 more
wiley   +1 more source

Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications

open access: yesHellenic Journal of Cardiology, 2020
Transthyretin cardiac amyloidosis (ATTR-CA) is a challenging and underdiagnosed cause of heart failure. Advances in cardiac imaging have enabled noninvasive diagnosis of ATTR-CA, causing the recent upsurge in disease awareness and detection.
Giedre Balciunaite   +12 more
doaj   +1 more source

A GROOVE Solution for the BPMN to BPEL Model Transformation [PDF]

open access: yes, 2009
In this paper we present a solution of a model transformation between two standard languages for business process modeling BPMN and BPEL, using the GROOVE tool set.
Mol, M.J. de, Zimakova, M.V.
core   +2 more sources

Home - About - Disclaimer - Privacy